Active Substance & Generic Molecule Directory
Oxytetracycline Hydrochloride in Malaysia: Registered Brands, Dosages & Price Comparison
Directory of all approved pharmaceutical brands containing Oxytetracycline Hydrochloride registered with the National Pharmaceutical Regulatory Agency (NPRA) / Ministry of Health Malaysia (KKM).
11
Registered Brands
Availability in Malaysia:
Showing 11 of 11 registered brands
| MAL Reg No | Brand Formulation Name | Strength / Dosage | Classification | Registration Holder | Action |
|---|---|---|---|---|---|
| MAL14070107HA | Alamycin 100mg/ml Solution for Injection. | 10 % (W/V) | Veterinary (MAL-V) | Borneosew Medical Trading (M) Sdn Bhd | Compare → |
| MAL23096030HA | NS-OTC, 500mg/g, Powder for use in drinking water | 539.6 mg 1 gm | Veterinary (MAL-V) | N.S. LABORATORY SDN. BHD. | Compare → |
| MAL20172815HA | OMS OSMOTET 500MG/G PREMIX POWDER | 500 mg in 1g | Veterinary (MAL-V) | Osmosis Nutrition Sdn Bhd | Compare → |
| MAL11010005HA | OTC-20 Premix Powder | 215.8 mg | Veterinary (MAL-V) | Y.S.P. INDUSTRIES (M) SDN. BHD. | Compare → |
| MAL19116018HA | OXYDEX 50% W/W WATER SOLUBLE POWDER | 500g In: 1kg | Veterinary (MAL-V) | Dexchem Industries Sdn Bhd | Compare → |
| MAL14090129HA | OXYSURE 50% POWDER | 500 g | Veterinary (MAL-V) | RANGE PHARMA SDN. BHD. | Compare → |
| MAL20172679HA | OxyTC 50% w/w Water Soluble Powder | 550mg/g | Veterinary (MAL-V) | Nam Pharma Sdn. Bhd. | Compare → |
| MAL11030007HA | Oxytet Powder 600mg/g. | 647.6 mg | Veterinary (MAL-V) | Y.S.P. INDUSTRIES (M) SDN. BHD. | Compare → |
| MAL17086048HAC | OXYTETRAVET HCL 50% W/W WATER SOLUBLE POWDER | 500 mg 1 g | Veterinary (MAL-V) | Lim Seng Pharmachem Sdn Bhd | Compare → |
| MAL17111017HA | PVP-OXYTETRACYCLINE 20% w/w POWDER | 215.84 mg | Veterinary (MAL-V) | Pelangi Vet Pharma Sdn. Bhd. | Compare → |
| MAL20046168HA | TP-OTC HCL 500MG/G WATER SOLUBLE POWDER | 500 mg 1 gm | Veterinary (MAL-V) | Thye Pharma Sdn. Bhd | Compare → |
Generic Bioequivalence & Drug Substitution in Malaysia
Generic medications registered under NPRA contain the identical active pharmaceutical ingredient (API) in identical dosage strength and route of administration as the originator brand. NPRA requires rigorous bioequivalence (BE) studies demonstrating that generic drugs deliver the exact therapeutic effect. Always confirm with your doctor or community pharmacist before switching between prescription brands.